openPR Logo
Press release

Global POC Diagnostic Market Set to Grow at 8.50% CAGR

12-10-2025 11:19 AM CET | Health & Medicine

Press release from: Expert Market Research

How Is the Point-of-Care (POC) Diagnostic Market Transforming Global Healthcare Delivery?

The Point-of-Care (POC) diagnostic market has become one of the most transformative segments in modern healthcare. As healthcare systems shift toward faster, more accessible, and decentralized testing methods, POC diagnostics play a central role in enabling rapid clinical decision-making. From glucose testing and infectious disease screening to cancer marker detection and cardiac monitoring, POC devices empower healthcare providers and patients with real-time health insights-reducing treatment delays, hospitalization rates, and laboratory burdens worldwide.

In 2025, the global point-of-care diagnostic market reached USD 16.33 Billion, driven by rapid technological advancements and rising global demand for easier and faster diagnostic tools. Forecasts indicate strong growth at a CAGR of 8.50% between 2026 and 2035, culminating in a market value of USD 36.92 Billion by 2035.

This growth is fueled by the increasing prevalence of chronic and infectious diseases, the rising adoption of home-based and remote diagnostics, and growing demand for decentralized healthcare-especially in low- and middle-income regions.

Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/point-of-care-poc-diagnostic-market/requestsample.

Understanding the Point-of-Care Diagnostic Market

Point-of-care diagnostics refer to medical tests conducted near or at the site of patient care rather than in centralized laboratories. These test kits and devices provide results within minutes or hours, enabling accelerated decision-making for disease detection, monitoring, and management.

POC diagnostics are widely used across:

Hospitals

Emergency rooms

Clinics

Homecare settings

Remote healthcare programs

Community outreach initiatives

Disaster and emergency response settings

The growing preference for early diagnosis and preventive healthcare is accelerating demand for POC innovations. The market's evolution is being shaped by advancements in microfluidics, AI-integrated biosensors, molecular diagnostics, and digital health platforms.

Key Market Drivers

1. Rising Burden of Chronic and Infectious Diseases

Chronic illnesses such as diabetes, cardiovascular disease, and kidney disorders require continuous monitoring. At the same time, infectious diseases-from influenza to HIV-drive widespread use of rapid diagnostic kits.

POC diagnostics enable:

Early identification

Continuous monitoring

Timely intervention

Lowered hospitalization costs

2. Growing Demand for Home-Based Healthcare

Homecare adoption has soared due to aging populations, rising chronic disease prevalence, and the growth of telehealth services. POC devices allow patients to perform tests independently, share results remotely, and minimize clinic visits.

3. Technological Advancements

Innovations in biosensing, molecular detection, and microfluidics enhance the accuracy, portability, and affordability of diagnostic devices.

4. Faster Clinical Decision-Making

Immediate results help clinicians perform targeted interventions-especially critical in emergency care, trauma units, and infectious disease outbreaks.

5. Expanding Healthcare Access in Developing Regions

POC diagnostics are essential in regions lacking advanced laboratory infrastructure. They provide affordable, easy-to-use solutions for rural and remote communities.

Market Segmentation Overview

Below is a detailed breakdown of major segments shaping the POC diagnostic market.

Market Breakup by Product

1. Glucose Monitoring Kits

The largest product category, driven by the global rise in diabetes. Innovations include:

Bluetooth-enabled glucometers

Continuous glucose monitoring (CGM) integration

Smartphone-compatible testing tools

2. Infectious Disease Testing Kits

Essential for rapid detection of diseases such as HIV, malaria, COVID-19, TB, and influenza.

3. Pregnancy and Fertility Testing Kits

Widely adopted for home-based use. Increasing use of digital pregnancy tests supports this segment.

4. Haematology Testing Kits

Used to measure levels of hemoglobin, hematocrit, and other indicators of blood disorders.

5. Cardiometabolic Monitoring Kits

Used for cholesterol tests, hypertension monitoring, and cardiac enzymes.

6. Urinalysis Testing Devices

Used for UTI detection, metabolic disorder screening, and kidney function tests.

7. Coagulation Monitoring Kits

Primarily used by patients on anticoagulant therapy (e.g., warfarin or DOACs).

8. Tumor or Cancer Marker Testing Devices

Emerging category supported by rising cancer prevalence and demand for early detection.

9. Cholesterol Testing Strips

Commonly used in homecare and primary care settings.

10. Drugs of Abuse Testing Kits

Used by law enforcement agencies, employers, and healthcare institutions.

11. Faecal Occult Testing Kits

Crucial for colorectal cancer screening and gastrointestinal disease assessment.

12. Others

Includes POC tests for allergies, cardiac enzymes, dengue, and sexually transmitted diseases.

Market Breakup by Platform

1. Lateral Flow Assays (LFAs)

The most dominant platform, used widely in pregnancy tests, infectious disease kits, and rapid antigen testing.

2. Dipsticks

Low-cost, easy-to-use tools for urinalysis and basic screening.

3. Microfluidics

A fast-growing area that improves test speed, accuracy, and portability using miniaturized fluid channels.

4. Molecular Diagnostics

Includes PCR-based and isothermal amplification technologies-critical for high-precision infectious disease detection.

5. Immunoassays

Provide fast results for detecting antigens and antibodies.

6. Others

Includes biosensors, electrochemical systems, and AI-integrated portable analyzers.

Market Breakup by Mode of Purchase

1. Prescription-Based Products

Used in clinical settings, especially for advanced biomarker testing and professional monitoring.

2. Over-The-Counter (OTC) Products

Mass-market growth is driven by rising consumer awareness and demand for:

Digital diagnostic tools

Self-testing kits

At-home wellness monitoring

Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/point-of-care-poc-diagnostic-market.

Market Breakup by End User

1. Professional Diagnostic Centres

Conduct rapid tests for immediate reporting while reducing laboratory load.

2. Hospitals and Critical Care Centres

Used for emergency, trauma, ICU, and surgical care where time-sensitive decision-making is essential.

3. Assisted Living Healthcare Facilities

Support elderly care, chronic disease monitoring, and routine testing at nursing homes.

4. Research Laboratories

Utilized for point-of-care innovation, clinical trials, and device performance evaluation.

Market Breakup by Region

1. North America

Dominates the market due to:

Advanced healthcare infrastructure

Early adoption of digital diagnostics

Strong presence of leading manufacturers

2. Europe

Emphasis on preventive care and rapid disease detection fuels stable market growth.

3. Asia Pacific

Expected to witness the fastest growth due to:

Rising chronic disease burden

Expanding healthcare access

Large aging population

4. Latin America

Growing investment in infectious disease testing programs contributes to increased adoption.

5. Middle East and Africa

Demand driven by need for decentralized healthcare, especially in rural areas.

Competitive Landscape

Major companies operating in the POC diagnostic industry include:

Abbott Point of Care Inc.

F. Hoffmann-La Roche Ltd

Chembio Diagnostics, Inc.

Johnson & Johnson Services, Inc.

Siemens AG

Becton, Dickinson and Company

Danaher Corp

These manufacturers are focused on:

Developing AI-enabled diagnostic tools

Improving molecular POC test accuracy

Expanding product portfolios

Enhancing connectivity and data analytics

Entering emerging global markets

Future Market Trends

The next decade will see the global POC diagnostics market accelerate as healthcare models shift toward decentralized, preventive, and personalized care.

1. Rise of Molecular POC Testing

PCR-equivalent rapid tests will become mainstream, enabling highly accurate diagnosis outside the lab.

2. Integration with Artificial Intelligence

AI-powered diagnostic reading can reduce errors and improve clinical decision-making.

3. Growing Use of Connectivity and Cloud Reporting

Data from POC devices will sync with electronic health records (EHRs) for seamless patient management.

4. Demand for Affordable Diagnostics in Low-Resource Regions

Governments and NGOs are increasing investments in POC programs targeting malaria, TB, HIV, and maternal health.

5. Expansion of At-Home Testing

Consumers want fast, digital, and self-administered tests for wellness and disease monitoring.

Explore More Reports

Diabetic Neuropathy Market - https://bit.ly/3LZqfY5.

Cranial Implants Market - https://bit.ly/3XSH61i.

Dyspepsia Market - https://bit.ly/4agZet7.

Implantable Medical Devices Market - https://bit.ly/3MfEzM7.

Media Contact

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global POC Diagnostic Market Set to Grow at 8.50% CAGR here

News-ID: 4309661 • Views:

More Releases from Expert Market Research

Peripheral Neuropathy Treatment Market Forecast to Hit USD 1.14B
Peripheral Neuropathy Treatment Market Forecast to Hit USD 1.14B
What Is Driving the Growth of the Peripheral Neuropathy Treatment Market Today? The peripheral neuropathy treatment market is expanding steadily as global awareness, diagnostic accuracy, and treatment accessibility continue to improve. Peripheral neuropathy, a condition caused by damage to the peripheral nervous system, affects millions worldwide-most commonly individuals living with diabetes, autoimmune disorders, infections, vitamin deficiencies, and chemotherapy-related nerve damage. With chronic diseases rising sharply, the demand for effective treatment options-both
Textile Dyes Market Analysis - Size, Trends, Growth, and Forecast (2026-2035)
Textile Dyes Market Analysis - Size, Trends, Growth, and Forecast (2026-2035)
The textile dyes market is anticipated to reach USD 19.43 billion by 2035, growing from USD 10.75 billion in 2025. The market is projected to expand at a compound annual growth rate (CAGR) of 6.10% from 2026 to 2035. This growth is driven by the increasing demand for colored textiles across various industries, including fashion, home furnishings, and automotive. In this blog, we will explore the textile dyes market's overview,
Oxygen Therapy Market Forecast to Grow at 6.83% CAGR by 2035
Oxygen Therapy Market Forecast to Grow at 6.83% CAGR by 2035
What is driving the growth of the Oxygen Therapy Market globally? Oxygen therapy is a medical intervention that delivers supplemental oxygen to patients suffering from respiratory disorders or other conditions that compromise oxygen levels in the blood. The global demand for oxygen therapy has grown significantly due to increasing incidences of chronic respiratory diseases, rising geriatric populations, and favorable government incentives supporting oxygen therapy devices. The global oxygen therapy market was valued
Global Osteoarthritis Therapeutics Market to Hit USD 22.85Bn by 2035
Global Osteoarthritis Therapeutics Market to Hit USD 22.85Bn by 2035
What is driving the growth of the Osteoarthritis Therapeutics Market and how is it evolving globally? Osteoarthritis (OA) is a degenerative joint disease characterized by the gradual breakdown of cartilage, leading to pain, stiffness, and limited mobility. The rising prevalence of OA globally, especially among the aging population, has made the osteoarthritis therapeutics market a critical segment in musculoskeletal healthcare. Patients are increasingly seeking therapies that reduce pain, improve joint function,

All 5 Releases


More Releases for POC

Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market? The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market? The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes. Point-of-Care Molecular Diagnostic Platform 1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components: • Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics. • Device: The 1POT™ Duo
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more. The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Point of Care (POC) Coagulation Testing Devices
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652 The report provides a comprehensive analysis of company profiles listed below: - Abbott - Biomerieux - Danaher - F.